A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A pediatric brain tumor consortium (PBTC) study Meeting Abstract
| Authors: | Fangusaro, J.; Onar-Thomas, A.; Poussaint, T. Y.; Wu, S. J.; Ligon, A. H.; Lindeman, N.; Banerjee, A.; Packer, R. J.; Kilburn, L. B.; Pollack, I. F.; Jakacki, R. I.; Qaddoumi, I.; Fisher, P. G.; Dhall, G.; Baxter, P.; Kreissman, S. G.; Stewart, C. F.; Pfister, S. M.; Jones, D. T. W.; Vezina, G.; Stern, J.; Panigrahy, A.; Jones, B. V.; Patay, Z.; Tamrazi, B.; Jones, J. Y.; Haque, S. S.; Enterline, D. S.; Cha, S.; Doyle, L. A.; Smith, M.; Boyett, J. M.; Dunkel, I. J.; Fouladi, M. |
| Abstract Title: | A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A pediatric brain tumor consortium (PBTC) study |
| Meeting Title: | 4th Biennial Conference on Pediatric Neuro-Oncology Basic and Translational Research |
| Journal Title: | Neuro-Oncology |
| Volume: | 19 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2017 Jun 15-16 |
| Meeting Location: | New York, NY |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-06-01 |
| Start Page: | iv34 |
| End Page: | iv35 |
| Language: | English |
| ACCESSION: | WOS:000402766800143 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/nox083.141 |
| PMCID: | PMC5475130 |
| Notes: | Meeting Abstract: LGG-08 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work